Financial Reports Latest Updates Industry Maps Economic Calendar

STANDARD BIOTOOLS INC. (LAB) Annual Reports

Q: Where can I read STANDARD BIOTOOLS INC. (LAB) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

STANDARD BIOTOOLS INC. is listed on Nasdaq, classified by the SEC under Pharmaceutical Preparations (SIC 2834). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 1162194 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$20.1M	$21.8M	-7.6%
Operating income	$-25.4M	$-25.7M	+1.2%
Net income	$-26.8M	$-33.5M	+20.0%
EPS (diluted)	$-0.07	$-0.09	+22.2%

Company guidance
	Period	Range
Revenue	FY2026	$80M – $85M

Figures are the company’s own outlook as stated in its earnings release, not analyst estimates.

Source: SEC EDGAR (XBRL company facts); guidance from Form 8-K Exhibit 99.1

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 20.1 mn Net income -26.8 mn

Show table：Income statement

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	25.4	8.02	8.47	10.4	8.70	10.6	10.6	13.0	10.9	12.9	12.8	15.7	14.5	17.5	18.3	20.9	25.7	27.6	29.6	33.5	26.7	28.6	28.6	30.7	29.0	28.2	22.2	25.1	25.5	23.9	24.8	27.8	—	25.3	26.4	29.0	32.3	30.1	28.2	26.5	32.4	27.6	26.1	39.9	44.6	32.8	31.0	28.5	38.3	26.5	18.8	25.6	27.0	25.1	27.7	25.4	28.2	45.5	37.2	45.0	46.7	40.8	21.8	19.6	23.8	21.1	20.1
Gross profit	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	58.4	—	—	—	52.0	—	13.4	13.6	15.8	18.8	17.0	15.4	14.0	17.5	13.0	11.8	20.8	22.1	—	—	—	—	—	4.43	9.22	11.2	12.3	13.6	11.2	13.4	24.2	14.9	23.3	21.9	19.7	10.6	9.48	11.4	11.3	10.5
Operating income	-18.0	-4.23	-3.10	-2.01	-4.88	-6.65	-4.05	-2.98	-6.28	-4.39	-3.91	-3.49	-5.07	-3.99	-4.95	-4.64	-16.6	-12.4	-13.1	-9.83	-14.0	-14.7	-7.80	-13.7	-18.9	-18.1	-18.5	-17.7	-17.5	-16.5	-15.6	-8.73	—	-12.6	-12.8	-11.6	-11.1	-14.2	-14.6	-13.8	-9.18	-14.9	-13.7	-5.46	-16.9	-19.3	-17.3	-19.6	-11.3	-27.5	-38.6	-29.0	-21.1	-16.6	-17.4	-21.2	-21.4	-60.2	-50.5	-31.7	-32.8	-33.0	-25.7	-32.9	-24.6	-12.5	-25.4
Net income	-19.1	-4.82	-3.38	-3.08	-7.34	-7.19	-4.49	-3.46	-6.69	-4.58	-4.15	-3.60	-3.55	-4.05	-4.29	-4.64	-15.4	-12.7	-13.8	-10.9	-15.9	-15.2	-9.27	-12.9	-19.9	-18.6	-19.8	-17.7	-17.2	-16.9	-15.9	-10.5	—	-13.3	-16.2	-14.8	-14.8	-25.5	-13.8	-12.9	-12.7	-16.0	-13.0	-6.00	-18.0	-18.8	-17.1	-13.8	-9.43	-76.3	-63.5	-29.4	-20.8	-16.8	-17.0	-21.0	-19.8	-32.2	-45.7	-26.9	-34.1	-26.0	-33.5	-34.7	19.3	127	-26.8

Balance sheet

Quarterly · In mn (USD)

Total assets 627 mn Total liabilities 87.3 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	—	—	20.9	—	81.0	76.0	70.0	56.7	55.7	106	101	98.6	80.5	86.7	105	179	127	133	156	155	143	145	144	138	127	108	96.7	86.1	79.1	96.2	94.8	95.0	81.0	75.3	71.9	127	111	107	96.5	96.1	82.4	78.5	123	118	96.3	78.2	73.5	72.1	73.2	251	229	209	195	183	171	158	548	480	454	376	344	506	472	454	521	517
Total assets	—	—	—	24.8	—	85.7	82.6	79.3	70.7	64.9	117	114	113	112	114	117	425	418	410	408	395	389	378	371	354	342	320	306	292	279	292	287	288	270	259	252	304	291	284	269	265	290	282	323	325	305	289	282	275	272	441	415	390	372	356	339	323	778	709	682	612	580	557	540	568	639	627
Current liabilities	—	—	—	18.5	—	17.8	19.7	20.2	17.7	14.8	13.1	11.6	11.5	11.6	15.0	17.9	25.7	27.3	27.3	29.4	24.9	28.9	27.5	30.1	30.5	32.3	27.9	29.5	31.3	34.3	31.9	33.5	—	33.7	36.6	38.9	37.6	34.2	37.3	33.4	32.8	35.4	38.4	42.8	54.3	53.5	52.9	47.3	49.6	47.2	42.8	46.2	43.4	43.8	46.8	51.8	109	122	124	121	65.9	56.2	98.0	108	108	42.2	56.8
Total liabilities	—	—	—	29.4	—	23.4	23.4	22.4	18.8	16.0	14.4	13.1	13.1	13.6	17.2	20.5	257	256	256	257	253	256	254	256	255	258	252	253	254	255	253	256	—	221	224	230	232	109	111	107	111	149	150	171	186	182	180	183	181	250	167	166	161	158	158	160	160	200	198	192	141	125	132	140	143	78.0	87.3
Equity	-174	—	—	-189	—	62.3	59.1	56.9	51.9	48.9	103	101	100	98.4	97.0	96.4	167	162	155	150	142	133	124	115	99.0	84.3	68.0	53.2	38.5	23.9	39.1	30.9	31.3	48.6	34.8	22.4	72.1	182	173	163	154	142	133	152	139	123	109	99.3	94.6	22.1	-37.5	-62.8	-81.5	-97.2	-113	-132	-148	577	510	489	472	455	425	400	424	561	540

Cash flow

Quarterly · In mn (USD)

Operating -10.3 mn Investing 14.4 mn Financing -0.14 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	-19.5	-6.03	-3.22	-2.26	-1.23	-11.7	-2.38	-2.25	-6.64	-4.00	-3.34	-3.50	-0.88	-2.64	-1.31	3.24	-10.6	0.31	-8.86	-3.52	-9.80	-7.83	-12.7	-4.37	-7.79	-7.35	-13.2	-10.7	-8.49	-8.29	-7.98	0.66	—	-16.2	-4.32	-4.06	-0.64	-20.1	-5.01	-4.55	-5.52	-4.29	-2.79	-4.60	-3.73	-12.9	-14.7	-9.49	-7.00	-15.6	-30.0	-24.6	-19.2	-8.48	-9.33	-11.4	-14.1	-62.5	-39.0	-27.9	-14.1	-30.3	-20.7	-22.2	-1.19	-46.6	-10.3
Investing	-0.69	-0.53	-0.47	-0.33	-22.1	-32.9	4.89	4.96	4.57	6.59	5.29	-2.44	2.40	-27.5	-12.1	9.62	-121	-58.9	-3.95	5.65	10.1	-6.86	17.7	4.84	21.2	0.29	9.82	13.8	17.5	3.59	0.45	-3.88	—	-0.26	4.20	0.8	-0.02	-9.76	-35.5	6.55	-0.55	17.5	10.1	13.2	-0.82	-4.92	-4.17	-1.71	-1.14	-0.87	-138	10.7	40.2	43.1	40.1	-49.9	-13.1	318	50.3	-30.9	25.7	14.6	27.5	-6.68	-8.04	191	14.4
Financing	16.9	0.01	0.65	3.13	73.4	-1.21	-0.8	-1.06	-3.04	-1.13	54.1	-1.43	1.77	0.65	1.08	2.31	198	1.17	0.63	1.03	3.73	1.40	0.14	0.03	0.01	0.13	-0.04	-0.02	0	-0.05	28.9	0.18	—	-0.06	-2.09	-0.14	60.0	0.15	1.04	-0.18	1.78	-0.5	0.51	20.4	0.43	-1.03	-0.13	9.82	7.30	18.1	213	0	-0.27	-2.56	-2.08	-1.16	-1.00	-19.7	-28.4	0	-54.5	-0.05	0.11	-0.11	0.62	-0.04	-0.14
Cash at period end	14.6	8.07	5.08	5.72	55.8	10.1	11.9	13.6	8.50	9.85	66.0	58.6	61.8	32.3	20.1	35.3	101	43.7	30.9	33.7	37.0	23.8	28.8	29.1	42.9	35.9	32.3	35.0	44.1	39.6	60.9	58.1	—	42.0	39.4	35.8	95.4	65.6	24.1	25.9	21.7	35.0	43.0	72.3	68.5	49.7	30.9	29.3	28.4	30.0	74.4	60.2	81.3	114	142	79.7	51.7	287	270	211	167	151	159	129	121	266	270

Profitability

Quarterly · %

Gross margin 52.4% Operating margin -126.3% Net margin -133.1%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Gross margin	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	233.0%	—	—	—	187.4%	—	53.2%	51.4%	54.6%	58.2%	56.4%	54.5%	53.0%	54.1%	47.1%	45.4%	52.2%	49.5%	—	—	—	—	—	23.6%	36.0%	41.3%	48.9%	49.2%	44.0%	47.4%	53.1%	40.1%	51.7%	46.9%	48.4%	48.8%	48.5%	47.8%	53.5%	52.4%
Operating margin	-71.0%	-52.7%	-36.6%	-19.4%	-56.1%	-62.9%	-38.3%	-22.9%	-57.4%	-33.9%	-30.6%	-22.3%	-34.9%	-22.8%	-27.1%	-22.2%	-64.5%	-44.8%	-44.0%	-29.4%	-52.4%	-51.2%	-27.2%	-44.6%	-65.1%	-64.4%	-83.3%	-70.5%	-68.7%	-69.0%	-63.0%	-31.5%	—	-50.0%	-48.4%	-40.1%	-34.4%	-47.2%	-51.9%	-52.1%	-28.3%	-54.1%	-52.7%	-13.7%	-37.9%	-58.9%	-55.7%	-68.8%	-29.4%	-103.8%	-205.4%	-113.2%	-78.1%	-66.1%	-63.1%	-83.5%	-75.9%	-132.2%	-135.8%	-70.5%	-70.2%	-80.8%	-118.1%	-168.5%	-103.6%	-59.1%	-126.3%
Net margin	-75.3%	-60.1%	-39.9%	-29.7%	-84.4%	-68.0%	-42.4%	-26.6%	-61.1%	-35.4%	-32.5%	-23.0%	-24.4%	-23.1%	-23.4%	-22.2%	-59.9%	-45.9%	-46.5%	-32.7%	-59.6%	-53.2%	-32.4%	-41.9%	-68.6%	-66.1%	-89.2%	-70.5%	-67.4%	-70.8%	-64.4%	-37.7%	—	-52.5%	-61.5%	-50.9%	-45.7%	-84.6%	-48.8%	-48.6%	-39.1%	-57.9%	-50.0%	-15.1%	-40.4%	-57.4%	-55.3%	-48.6%	-24.6%	-287.8%	-338.4%	-114.7%	-77.1%	-67.0%	-61.6%	-82.8%	-70.2%	-70.6%	-122.9%	-59.9%	-72.9%	-63.8%	-153.8%	-177.4%	81.0%	600.9%	-133.1%

Returns & leverage

Quarterly · %

ROE 17.6% ROA 14.3% Debt ratio 13.9%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	—	—	-33.7%	-37.4%	—	-42.0%	-34.5%	-23.3%	-24.1%	-20.9%	-20.8%	-15.5%	-16.8%	-21.2%	-28.5%	-37.0%	-42.8%	-34.4%	-37.9%	-36.9%	-40.2%	-47.4%	-55.8%	-74.1%	-90.4%	-106.6%	-132.4%	-126.6%	-143.8%	—	—	—	—	-114.1%	-61.7%	-66.3%	-72.3%	-57.4%	-34.2%	-35.7%	-30.3%	-36.2%	-42.3%	-49.5%	-54.0%	-50.7%	-160.9%	-453.1%	-976.7%	-2895.8%	—	—	—	—	-37.5%	-59.8%	-69.7%	-85.8%	-25.7%	-25.8%	-28.9%	-16.7%	15.4%	17.6%
ROA	—	—	—	-122.6%	—	-24.5%	-26.7%	-43.2%	-30.9%	-25.5%	-18.9%	-19.7%	-17.3%	-17.4%	-13.4%	-14.3%	-10.6%	-14.0%	-17.7%	-20.1%	-13.0%	-13.9%	-13.0%	-13.7%	-15.3%	-16.6%	-20.4%	-22.4%	-22.7%	-23.1%	-22.1%	-20.4%	—	—	—	—	-20.0%	-25.4%	-25.3%	-25.6%	-22.8%	-19.0%	-19.3%	-16.1%	-18.0%	-18.8%	-21.0%	-22.4%	-19.8%	-40.4%	-44.7%	-51.3%	-57.1%	-40.6%	-21.1%	-20.1%	-20.9%	-15.7%	-22.3%	-24.4%	-29.7%	-19.6%	-19.0%	-21.0%	-12.7%	12.8%	14.3%
Debt ratio	—	—	—	118.6%	—	27.3%	28.4%	28.3%	26.6%	24.7%	12.3%	11.5%	11.6%	12.1%	15.1%	17.5%	60.6%	61.3%	62.3%	63.1%	63.9%	65.8%	67.2%	69.0%	72.1%	75.4%	78.8%	82.6%	86.8%	91.4%	86.6%	89.2%	—	82.0%	86.6%	91.1%	76.3%	37.5%	39.2%	39.6%	42.0%	51.3%	53.0%	53.0%	57.2%	59.7%	62.2%	64.8%	65.6%	91.9%	37.9%	40.1%	41.1%	42.4%	44.4%	47.1%	49.5%	25.8%	28.0%	28.2%	23.0%	21.6%	23.8%	25.9%	25.3%	12.2%	13.9%

EPS

Quarterly · US$

EPS US$-0.07

Show table：EPS

Item	2009Q4	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.97	—	-0.18	-0.08	-0.25	-0.25	-0.23	-0.18	-0.12	-0.99	-0.82	-0.37	-0.26	-0.21	-0.22	-0.27	-0.25	-0.27	-0.12	-0.07	-0.08	-0.07	-0.09	-0.09	0.05	0.33	-0.07

Revenue & profit

Year-to-date · In mn (USD)

Revenue 41.3 mn Net income 100 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 627 mn Total liabilities 87.3 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating -56.9 mn Investing 206 mn Financing -0.18 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Gross margin 53.0% Operating margin -91.8% Net margin 243.2%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE 17.6% ROA 14.3% Debt ratio 13.9%

EPS

Year-to-date · US$

EPS US$0.26

Revenue & profit

Annual · In mn (USD)

Revenue 106 mn Net income -74.9 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	42.9	52.3	71.2	116	115	104	102	—	117	138	131	98.0	106	174	106
Gross profit	—	—	—	—	—	—	—	—	63.9	67.7	—	—	50.4	84.3	51.2
Operating income	-18.6	-18.1	-18.6	-51.8	-50.1	-73.2	-58.4	—	-51.8	-51.0	-67.5	-116	-76.6	-175	-116
Net income	-22.5	-19.0	-16.5	-52.8	-53.3	-76.0	-60.5	—	-64.8	-53.0	-59.2	-190	-74.7	-139	-74.9

Balance sheet

Annual · In mn (USD)

Total assets 568 mn Total liabilities 143 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	70.0	101	105	156	144	96.7	94.8	127	96.1	118	72.1	209	158	376	454
Total assets	79.3	114	117	408	371	306	287	304	265	325	275	390	323	612	568
Current liabilities	20.2	11.6	17.9	29.4	30.1	29.5	33.5	37.6	32.8	54.3	49.6	43.4	109	65.9	108
Total liabilities	22.4	13.1	20.5	257	256	253	256	232	111	186	181	161	160	141	143
Equity	56.9	101	96.4	150	115	53.2	30.9	72.1	154	139	94.6	-81.5	-148	472	424

Cash flow

Annual · In mn (USD)

Operating -74.3 mn Investing 27.4 mn Financing 0.57 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	-17.5	-17.5	-1.59	-22.6	-34.7	-39.1	-24.1	—	-35.2	-15.4	-44.1	-89.4	-43.3	-143	-74.3
Investing	-45.1	14.0	-27.6	-178	25.7	45.1	17.7	—	-39.3	40.0	-11.9	-88.1	20.2	363	27.4
Financing	70.4	48.5	5.81	200	5.30	0.08	29.0	—	2.79	20.9	16.0	231	-6.81	-103	0.57
Cash at period end	13.6	58.6	35.3	33.7	29.1	35.0	58.1	95.4	21.7	68.5	28.4	81.3	51.7	167	121

Profitability

Annual · %

Gross margin 48.4% Operating margin -109.8% Net margin -70.7%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Gross margin	—	—	—	—	—	—	—	—	54.5%	49.0%	—	—	47.4%	48.3%	48.4%
Operating margin	-43.3%	-34.5%	-26.2%	-44.5%	-43.7%	-70.1%	-57.3%	—	-44.2%	-36.9%	-51.7%	-118.6%	-72.0%	-100.5%	-109.8%
Net margin	-52.4%	-36.4%	-23.2%	-45.4%	-46.5%	-72.8%	-59.4%	—	-55.3%	-38.4%	-45.4%	-194.1%	-70.2%	-79.6%	-70.7%

Returns & leverage

Annual · %

ROE -16.7% ROA -12.7% Debt ratio 25.3%

Show table：Returns & leverage

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	-39.5%	-24.1%	-16.8%	-42.8%	-40.2%	-90.4%	-143.8%	—	-57.4%	-36.2%	-50.7%	-2895.8%	—	-85.8%	-16.7%
ROA	-28.3%	-19.7%	-14.3%	-20.1%	-13.7%	-22.4%	-20.4%	—	-22.8%	-18.0%	-19.8%	-57.1%	-20.9%	-29.7%	-12.7%
Debt ratio	28.3%	11.5%	17.5%	63.1%	69.0%	82.6%	89.2%	76.3%	42.0%	57.2%	65.6%	41.1%	49.5%	23.0%	25.3%

EPS

Annual · US$

EPS US$-0.20

Show table：EPS

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	—	—	—	—	—	—	—	—	—	—	-0.78	-2.44	-0.95	-0.54	-0.20

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read STANDARD BIOTOOLS INC. (LAB) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.